Literature DB >> 2157468

Angiotensin II receptors in the kidney. Localization and physiological significance.

H Yamada1, P M Sexton, S Y Chai, W R Adam, F A Mendelsohn.   

Abstract

Angiotensin II (Ang II) exerts a variety of actions through specific receptor binding in the kidney. These include modulation of renal hemodynamics, glomerular filtration rate (GFR), and tubular reabsorption. Quantitative in vitro autoradiography was used to localize the Ang II receptors and angiotensin converting enzyme (ACE) in rat, rabbit, and human kidney. We incubated 20 microns cryostat sections of kidney with either 125I-[Sar1]Ang II or 125I-[Sar1,Ile8]Ang II for Ang II binding or with 125I-351A for ACE localization. The resulting autoradiographs were analyzed by computerized densitometry. A high density of Ang II binding was found over glomeruli and vasa recta bundles in all species examined. The interbundle area of the outer medulla was associated with low to moderate binding of Ang II. Moderate binding of Ang II was observed over proximal convoluted tubules in the outer cortex of rat kidney. ACE was predominantly distributed in proximal convoluted tubules in all species. These studies reveal multiple sites where Ang II could modulate renal function by acting on the renal vasculature, glomeruli, vasa recta bundles, and proximal tubular sites.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157468     DOI: 10.1093/ajh/3.3.250

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

Review 1.  Structure and function of podocytes: an update.

Authors:  P Mundel; W Kriz
Journal:  Anat Embryol (Berl)       Date:  1995-11

2.  Angiotensin II depolarizes podocytes in the intact glomerulus of the Rat.

Authors:  J Gloy; A Henger; K G Fischer; R Nitschke; P Mundel; M Bleich; P Schollmeyer; R Greger; H Pavenstädt
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

3.  Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule.

Authors:  H F Cheng; B N Becker; K D Burns; R C Harris
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

4.  ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.

Authors:  M-L Gross; A El-Shakmak; A Szábó; A Koch; A Kuhlmann; K Münter; E Ritz; K Amann
Journal:  Diabetologia       Date:  2003-06-11       Impact factor: 10.122

5.  A nephritogenic rat monoclonal antibody to mouse aminopeptidase A. Induction of massive albuminuria after a single intravenous injection.

Authors:  K J Assmann; J P van Son; H B Dijkman; R A Koene
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.